Literature DB >> 639045

Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro.

E van 't Hull, H Schellekens, B Löwenberg, M J de Vries.   

Abstract

The toxicity of interferon to bone marrow was studied by the use of in vitro colony forming assays for hemopoietic cells. In the same study the relative inhibitory effects of two clinically common interferon preparations, leukocyte and fibroblast interferons, were compared with regard to their effect on both myeloid [colony-forming unit, culture (CFUc)] and erythroid [colony-forming unit, erythroid (CFUe)] progenitor cells. CFUe formation in human bone marrow cells in vitro appeared to be fairly resistant to both interferons. Only high doses of both interferons gave a marked inhibition of CFUe. However, the toxicity of leukocyte and fibroblast interferon was divergent for CFUe in human bone marrow. Leukocyte interferon appeared to be considerably more inhibitory for CFUe than was fibroblast interferon. The effects of mouse interferon, induced in L929 cells, on the growth of CFUc and CFUe in murine bone marrow cells were comparable with those of fibroblast interferon on human cells. The toxicity of human and murine interferon was species specific. Except for the toxicity of leukocyte interferon to CFUc in human bone marrow, the toxicity of interferon was marked only with concentrations on interferon far exceeding the amount necessary to produce an antiviral state in vitro.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 639045

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Relationship between colony-stimulating activity and interferon production during infection.

Authors:  P Egan; C Cheers
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

3.  Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes.

Authors:  S W Mamus; S Beck-Schroeder; E D Zanjani
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

Review 4.  Differences between human alpha (leukocyte) and beta (fibroblast) interferons.

Authors:  T G Hayes
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

Review 5.  Interferon therapy: pharmacokinetic and pharmacological aspects.

Authors:  A Billiau
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

6.  Effects of human alpha-interferon on granulocyte-macrophage progenitor cells (CFU-GM) in vitro.

Authors:  J S Schwamborn; R M Nickels; B D Katthagen; H W Pees; P G Scheurlen
Journal:  Blut       Date:  1988-03

7.  Activation of protein kinase C{eta} by type I interferons.

Authors:  Amanda J Redig; Antonella Sassano; Beata Majchrzak-Kita; Efstratios Katsoulidis; Hui Liu; Jessica K Altman; Eleanor N Fish; Amittha Wickrema; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

8.  Role of lipopolysaccharide in regulating colony-stimulating factor-dependent macrophage proliferation in vitro.

Authors:  R N Moore; P S Steeg; D N Männel; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

9.  Prostaglandin regulation of colony-stimulating factor production by lipopolysaccharide-stimulated murine leukocytes.

Authors:  R N Moore; R Urbaschek; L M Wahl; S E Mergenhagen
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

10.  Colony-stimulating activity induced by synthetic muramyl peptides: variation with chemical structure and association with anti-infectious activity.

Authors:  A Galelli; P Lefrancier; L Chedid
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.